Background Autism spectrum disorders (ASD) occur in 1.5% of the general population
worldwide. Studies suggest that ASD might have more costs than diabetes and attention …

Objective This meta-analysis examined the efficacy of available pharmacological and
nonpharmacological interventions for irritability among youth with autism spectrum disorder …

Background The net health benefit of using antipsychotics in children and adolescents with
ASD is unclear. This review was performed to provide the evidence necessary to inform the …

In the last decade there has been a revolution in terms of genetic findings in
neurodevelopmental disorders (NDDs), with many discoveries critical for understanding …

Statins are widely accepted as first-choice agents for the prevention of lipid-related
cardiovascular diseases. These drugs have both anti-inflammatory and anti-oxidant …

Introduction Autism spectrum disorder (ASD) is an early-onset disorder with a prevalence of
1% among children and reported disability-adjusted life years of 4.31 million. Irritability is a …

Objectives This study aimed to evaluate efficacy and safety of prednisolone as an adjunctive
treatment to risperidone, in children with regressive autism spectrum disorder (ASD) …

Introduction and objectives: Vortioxetine, a novel antidepressant, may be an interesting
candidate for adjunctive therapy of schizophrenia. Our primary objective was to investigate …

Inflammation as well as glutamate excitotoxicity have been proposed to participate in the
propagation of autism. Palmitoylethanolamide (PEA) is an endocannabinoid proven to …

Objectives: This study aimed at investigating the efficacy and tolerability of l-carnosine as an
add-on to risperidone in the management of children with autism. Methods: This was a 10 …